Overview

A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This is a two-week study testing the efficacy and safety of mifepristone in the prevention of olanzapine-induced weight gain in healthy male volunteers by measuring changes in body weight and BMI.
Phase:
Phase 2
Details
Lead Sponsor:
Corcept Therapeutics
Collaborator:
Eli Lilly and Company
Treatments:
Mifepristone
Olanzapine